US Customs Ruling (CROSS)
 HS Code : | | |
|---|
 HTS Code : | | |
|---|
| CAS Number : | |
|---|
Ruling Number :
Issuing Country : UNITED STATES
Date Of Issue : 2018-08-14T00:00:00
Sparsentan (CAS No. 254740-64-2) in bulk powder form
The tariff classification of Sparsentan (CAS No. 254740-64-2) in bulk powder form, from China. Sparsentan, is a dual-acting angiotensin and endothelin receptor antagonist (DARA) that is being developed by Retrophin, Inc. for the treatment of focal segmental glomerulosclerosis (FSGS), a serious kidney disorder that often leads to end-stage renal disease. In your letter, you state that Retrophin, Inc. has successfully concluded Phase II trials of Sparsentan and anticipates Phase III trials will be commenced shortly.
Description : Sparsentan in bulk powder form
Please importantly note that only the relevant portion of the related US Ruling (Cross) is displayed above. You may refer to the said customs ruling for the entire ruling explanation.
Source : US Customs Ruling (CROSS)
source link :